Augurex Life Sciences
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
220 887 Great Northern Way, Vancouver, B...Phone Number
(604) 637-3280Website
www.augurex.comRevenue
$6.1 MillionIndustry
About Augurex Life Sciences
Augurex Life Sciences Org Chart
Is Augurex Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Augurex Life Sciences
Product Launch: Get notified when Augurex Life Sciences launches new products
Check out if Augurex Life Sciences is spiking on competitors!
Click to see if Augurex Life Sciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Augurex Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Augurex Life Sciences has new funding data
Augurex Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Augurex Life Sciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Augurex Life Sciences
Compare insights from companies similar to Augurex Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Augurex Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Augurex Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Augurex Life Sciences.
Augurex Life Sciences Tech Stack
A closer look at the technologies used by Augurex Life Sciences
Augurex Life Sciences News & Media
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a leading provider of diagnostic information services, under which Quest will validate and offer a lab-developed test based on the Augurex 14-3-3η (eta) biomarker in the United States. Quest intends to begin offering the test service to physicians from its advancAugurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis
VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test that assists clinicians in the diagnosis of axial spondyloarthritis (axSpA). New Day Diagnostics in Knoxville, TN, developed the diagnostic test using the Anti-14-3-3eta Multiplex ASRs as components and now offers theAugurex to Present Axial Spondyloarthritis Data and Exhibit at ACR Convergence 2024 in Washington, DC
VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced its participation at the American College of Rheumatology (ACR) Convergence 2024, taking place in Washington, DC from November 14-19. Augurex will present a poster and exhibit its latest research and innovations in autoimmune diagnostics, including the 14-3-3η biomarker for rheumatoid arthritis (RA) and the newly launched 14-3-3ηAugurex Announces Agreement with ARUP Laboratories to Expand Access to Advanced Rheumatoid Arthritis Diagnosis with the Launch of 14-3-3η (eta) Test
VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that ARUP Laboratories, a leading national reference laboratory in the U.S., has launched the 14-3-3η test as part of their diagnostic testing portfolio. This agreement is poised to significantly enhance the early detection and management of rheumatoid arthritis (RA), providing clinicians with an important tool to improve patient
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Augurex Life Sciences
Augurex is a leader in clinical diagnostics, specializing in biomarker-driven tests for autoimmune conditions. The company is dedicated to delivering transformative tools that improve lives and reduce the burden of chronic disease. With over 10 years of experience, Augurex provides innovative solutions that enable personalized treatment plans for b... Read More